idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Grafik: idw-Logo

idw - Informationsdienst
Wissenschaft

Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instanz:
Teilen: 
28.06.2021 09:36

More effective and more versatile vaccines through bacterial secretions

Nina Grötschl Öffentlichkeitsarbeit und Kommunikation
Veterinärmedizinische Universität Wien

    In a recently published proof-of-concept study, researchers from the University of Veterinary Medicine in Vienna were able to demonstrate that so-called bacterial vesicles can have applications in the development of more versatile and more efficient vaccines. According to the researchers, the approximately virus-sized bacterial products could, for example, serve as an adjuvant to create a stronger immune response in vaccines.

    Bacteria release lipid-enclosed vesicles into the surrounding medium. These cell parts are known to be involved in many different cellular processes such as intercellular communication and waste disposal. Researchers from the Institute of Virology and the Institute of Immunology at Vetmeduni Vienna have now succeeded in positively exploiting (repurposing) these bacterial vesicles. By labelling these bacterial secretions with proteins from mammalian cells, they were able to generate more lifelike antigens. At the same time, the bacterial vesicles act as an immunologic adjuvant that triggers a stronger immune response. The result is a modular platform that could potentially enable a more targeted and faster development of vaccines.

    The trick: hybrids on a bacterial basis

    In their proof-of-concept study, the researchers from Vetmeduni Vienna, with the support of the Department of Pharmaceutical Sciences at the University of Vienna, examined the outer membrane vesicles (OMVs) of Escherichia coli (E. coli), bacteria that naturally occur in the intestines of healthy people. In their study, the researchers for the first time exploited a process already being successfully used by this working group in eukaryotic membranes. “By transferring the process of molecular painting or protein engineering to bacterial vesicles, we were able to generate a hybrid of perfectly eukaryotic proteins on a prokaryotic platform,” says first author Marianne Zaruba from the Institute of Virology at Vetmeduni Vienna.

    Researchers harness bacterial secretions as platform for novel vaccine strategy

    According to study director Christoph Metzner from the Institute of Virology at Vetmeduni Vienna, the E. coli vesicles have multiple benefits for novel vaccines: “The direct surface modification of outer membrane vesicles allows the deposition of eukaryotic proteins on a prokaryotic background. The immunostimulatory properties of the OMVs (e.g., B-cell stimulation) are not significantly changed. Parallel deposition of two different proteins is possible. In the development of novel vaccines, this would offer increased versatility and greater effectiveness against virus variants.” In addition to the fluorescent marker proteins used so far, cytokines, growth factors and antigens can also be transferred, generating a versatile modular platform for novel vaccine strategies.

    Prokaryotic and eukaryotic bacteria produce similar products

    Extracellular vesicles have recently attracted great attention, in part because of the emerging applications in gene therapy, vaccine production and diagnostics. Less well-known than their eukaryotic (organisms whose cells have a nucleus) counterparts, prokaryotic (unicellular organisms that lack a nucleus) bacteria also produce extracellular vesicles. In the case of E. coli, the main representatives are termed “outer membrane vesicles”.


    Wissenschaftliche Ansprechpartner:

    Christoph Metzner
    Institute of Virology
    University of Veterinary Medicine Vienna (Vetmeduni Vienna)
    Christoph.Metzner@vetmeduni.ac.at


    Originalpublikation:

    The article “Surface Modification of E. coli Outer Membrane Vesicles with Glycosylphosphatidylinositol-Anchored Proteins: Generating Pro/Eukaryote Chimera Constructs” by Marianne Zaruba, Lena Roschitz, Haider Sami, Manfred Ogris, Wilhelm Gerner and Christoph Metzner was published in Membranes. https://www.mdpi.com/2077-0375/11/6/428


    Weitere Informationen:

    https://www.vetmeduni.ac.at/en/infoservice/press-releases/presseinformationen-20...


    Bilder

    Merkmale dieser Pressemitteilung:
    Journalisten, jedermann
    Biologie, Medizin, Tier / Land / Forst
    überregional
    Forschungsergebnisse, Wissenschaftliche Publikationen
    Englisch


     

    Hilfe

    Die Suche / Erweiterte Suche im idw-Archiv
    Verknüpfungen

    Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.

    Klammern

    Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).

    Wortgruppen

    Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.

    Auswahlkriterien

    Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).

    Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).